Conversation with The Cancer LetterFree WVU’s Goldberg: Oregon draft guidance would widen disparities for low-income cancer patients September 26, 2018Vol.44 No.36By Matthew Bin Han Ong
Conversation with The Cancer LetterFree UIC’s Stewart: Oregon draft guidance is “an assault on the treatment of underrepresented populations” September 26, 2018Vol.44 No.36By Matthew Bin Han Ong
Free Oregon weighs plan to deny Medicaid payment for NGS as panel declares “no evidence of clinical utility” September 26, 2018By Matthew Bin Han Ong
FreeTrials & Tribulations Shrinking oncology phase I clinical trials: If the drug is a breakthrough, why would you ever want to utilize the maximally tolerated dose? September 21, 2018Vol.44 No.35By Mark J. Ratain
Senate passes conference bill, giving NIH $2 billion raise September 21, 2018Vol.44 No.35By Matthew Bin Han Ong
As José Baselga clears his desk, MSK forms task force on conflicts;meanwhile, new allegations emerge over center's role in AI start-up September 21, 2018Vol.44 No.35By Paul Goldberg
Free ASCO urges CMS to drop proposal that threatens to reduce access for Medicare cancer patients September 14, 2018Vol.44 No.34
Free A color-coded document Baselga created to explain himself instead illustrated the extent of his confusion and exposure September 14, 2018Vol.44 No.34By Paul Goldberg
Free José Baselga resigns as physician-in-chief at Memorial Sloan Kettering September 14, 2018Vol.44 No.34By Paul Goldberg and Matthew Bin Han Ong
Free José Baselga: “I take responsibility for failing to make appropriate disclosures” September 10, 2018By Matthew Bin Han Ong and Paul Goldberg
